When forming attitudes about embryonic stem cell research, people are influenced by a number of things. But understanding science plays a negligible role for many people.

A crisp new edition of a classic biochemistry text is now available from booksellers in college towns and online. And that means a team of UW-Madison scientists and illustrators campus can put their feet up for a while.

The structure of the life sciences industry is changing, says G. Steven Burrill, CEO of Burrill and Company, a life sciences investment firm based in San Francisco, speaking at UW-Madison on Feb. 21

In an effort to expand dietary options for individuals with a rare genetic condition known as phenylketonuria, a team of UW-Madison scientists is assessing a unique protein found only in whey, the liquid byproduct of cheese-making, that appears to be safe for this group to eat.

When biochemist Karl Paul Link examined a sample of bad forage, he discovered what would become one of the world’s best-known blood-thinning drugs

Julie Mitchell, assistant professor in the Department of Biochemistry and the Department of Mathematics, is one of several UW-Madison faculty members featured in a video […]

A new UW-Madison finding that pregnant women who take some types of vitamin supplements or eat fortified foods may be passing excess vitamin A to their developing fetuses could guide efforts to develop future formulations of vitamins.

When the University of Wisconsin football Badgers take the field this fall, they will have a secret weapon behind them: Wisconsin’s dairy cows. Sure, they might not run very well or catch a football, but cows supply one of the key ingredients in a sports recovery drink that the Badgers use to bounce back from strenuous workouts and practices.

Building creates an environment that encourages the cross-disciplinary work and discussion that can help solve problems and advance research

A study of the reproductive apparatus of a model virus is bolstering the idea that broad classes of viruses – including those that cause important human diseases such as AIDS, SARS and hepatitis C – have features in common that could eventually make them vulnerable to broad-spectrum antiviral agents.